Trial
NCT00642902
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
EMD Serono
Collaborators
—
Condition
Relapsing Multiple Sclerosis
Intervention
Atacicept
Why stopped
Sponsor voluntarily decided to terminate trial due to increased MS disease activity in atacicept arms as compared to placebo during a routine IDMC review.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-24